Literature DB >> 18446418

Radical redo surgery for local rectal cancer recurrence improves overall survival: a single center experience.

Paulus Schurr1, Edda Lentz, Suzette Block, Jussuf Kaifi, Helge Kleinhans, Guellue Cataldegirmen, Asad Kutup, Claus Schneider, Tim Strate, Emre Yekebas, Jakob Izbicki.   

Abstract

BACKGROUND: To date, the survival benefit of redo surgery in locally recurrent rectal adenocarcinoma remains unclear. STUDY
DESIGN: In an institutional study, operations for recurrence were retrospectively analyzed. Survival was calculated using the Kaplan-Meier plot and Cox regression analysis.
RESULTS: A total of 72 patients with local recurrence were explored or resected. In 38 patients, there was synchronous distant organ recurrence. Forty-five of 72 were re-resected and in 37 of 45 cases, R0 situations were achieved. In 11 of 38 metastasized patients, both local and distant organ recurrence were successfully removed. For obtaining tumor control, resections of inner genitals, bladder, and sacral bone were necessary in 10, 4, and 11 patients, respectively. Survival was better for patients re-resected with a median overall survival of 54.9 months, as compared with 31.1 months among non-resected patients (p = 0.0047, log-rank test). Subgroup analysis revealed that a benefit of re-resection was observed to a lesser extent in synchronous local and in distant disease. Cox analysis showed that initial Dukes stage and complete resections of local recurrences were independently determining prognosis (relative risk 1.762 and 0.689, p = 0.008 and p = 0.002, respectively).
CONCLUSIONS: Radical surgery for local recurrence can improve survival if complete tumor clearance is achieved, and concomitant distant tumor load should not principally preclude re-resection.

Entities:  

Mesh:

Year:  2008        PMID: 18446418     DOI: 10.1007/s11605-008-0517-8

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  25 in total

1.  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

Authors:  E Kapiteijn; C A Marijnen; I D Nagtegaal; H Putter; W H Steup; T Wiggers; H J Rutten; L Pahlman; B Glimelius; J H van Krieken; J W Leer; C J van de Velde
Journal:  N Engl J Med       Date:  2001-08-30       Impact factor: 91.245

2.  Sacral resection for recurrent rectal cancer: analysis of morbidity and treatment results.

Authors:  Genevieve B Melton; Philip B Paty; Patrick J Boland; John H Healey; Salvatore G Savatta; Jorge E Casas-Ganem; José G Guillem; Martin R Weiser; Alfred M Cohen; Bruce D Minsky; W Douglas Wong; Larissa K Temple
Journal:  Dis Colon Rectum       Date:  2006-08       Impact factor: 4.585

3.  Low rectal cancer: a call for a change of approach in abdominoperineal resection.

Authors:  Iris D Nagtegaal; Cornelius J H van de Velde; Corrie A M Marijnen; Jan H J M van Krieken; Philip Quirke
Journal:  J Clin Oncol       Date:  2005-12-20       Impact factor: 44.544

4.  Improved survival with preoperative radiotherapy in resectable rectal cancer.

Authors:  B Cedermark; M Dahlberg; B Glimelius; L Påhlman; L E Rutqvist; N Wilking
Journal:  N Engl J Med       Date:  1997-04-03       Impact factor: 91.245

5.  Radical and nerve-preserving surgery for rectal cancer in The Netherlands: a prospective study on morbidity and functional outcome.

Authors:  C P Maas; Y Moriya; W H Steup; G M Kiebert; W M Kranenbarg; C J van de Velde
Journal:  Br J Surg       Date:  1998-01       Impact factor: 6.939

6.  The influence of total mesorectal excision on local recurrence and survival in rectal cancer patients: a population-based study in Greater Amsterdam.

Authors:  O Visser; R Bakx; F A N Zoetmulder; C C Levering; S Meijer; J F M Slors; J J B van Lanschot
Journal:  J Surg Oncol       Date:  2007-05-01       Impact factor: 3.454

7.  Total mesorectal excision (TME) with or without preoperative radiotherapy in the treatment of primary rectal cancer. Prospective randomised trial with standard operative and histopathological techniques. Dutch ColoRectal Cancer Group.

Authors:  E Kapiteijn; E K Kranenbarg; W H Steup; C W Taat; H J Rutten; T Wiggers; J H van Krieken; J Hermans; J W Leer; C J van de Velde
Journal:  Eur J Surg       Date:  1999-05

Review 8.  Neoadjuvant radiotherapy and radiochemotherapy for rectal cancer.

Authors:  Claus Rödel; Rolf Sauer
Journal:  Recent Results Cancer Res       Date:  2005

9.  Improved survival and local control after total mesorectal excision or D3 lymphadenectomy in the treatment of primary rectal cancer: an international analysis of 1411 patients.

Authors:  K Havenga; W E Enker; J Norstein; Y Moriya; R J Heald; H C van Houwelingen; C J van de Velde
Journal:  Eur J Surg Oncol       Date:  1999-08       Impact factor: 4.424

10.  Locoregional recurrence and survival after curative resection of adenocarcinoma of the colon.

Authors:  Thomas E Read; Matthew G Mutch; Benjamin W Chang; Michael S McNevin; James W Fleshman; Elisa H Birnbaum; Robert D Fry; Philip F Caushaj; Ira J Kodner
Journal:  J Am Coll Surg       Date:  2002-07       Impact factor: 6.113

View more
  7 in total

1.  Impact of anatomic location on locally recurrent rectal cancer: superior outcome for intraluminal tumour recurrence.

Authors:  Johannes Klose; Ignazio Tarantino; Thomas Schmidt; Thomas Bruckner; Yakup Kulu; Tobias Wagner; Martin Schneider; Markus W Büchler; Alexis Ulrich
Journal:  J Gastrointest Surg       Date:  2015-03-31       Impact factor: 3.452

2.  Intensity-modulated radiation therapy for pelvic oligo-recurrence from rectal cancer: long-term results from a single institution.

Authors:  Xiang-Gao Zhu; Yong-Heng Li; Xiao-Fan Li; Yong Cai
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

3.  [Locally recurrent rectal cancer].

Authors:  A Troja; H R Raab
Journal:  Chirurg       Date:  2010-10       Impact factor: 0.955

Review 4.  A rare presentation of locally re-recurrent colon cancer involving the iliac bone and a review of the literature.

Authors:  Andrew Schumacher; Osman Mahdi Babikir; Amer Abboud; Spyridon Theodorakis
Journal:  BMJ Case Rep       Date:  2014-10-29

5.  Locally recurrent colorectal cancer: results of surgical therapy.

Authors:  M Kruschewski; M Ciurea; S Lipka; S Daum; L Moser; B Meyer; J Gröne; J Budczies; H J Buhr
Journal:  Langenbecks Arch Surg       Date:  2012-06-28       Impact factor: 3.445

Review 6.  Intentionally curative treatment of locally recurrent rectal cancer: a systematic review.

Authors:  Pieter J Tanis; Annemiek Doeksen; J Jan B van Lanschot
Journal:  Can J Surg       Date:  2013-04       Impact factor: 2.089

7.  Clinical outcomes of chemoradiotherapy for locally recurrent rectal cancer.

Authors:  Joo Ho Lee; Dae Yong Kim; Sun Young Kim; Ji Won Park; Hyo Seong Choi; Jae Hwan Oh; Hee Jin Chang; Tae Hyun Kim; Suk Won Park
Journal:  Radiat Oncol       Date:  2011-05-20       Impact factor: 3.481

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.